Skip to main content
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
6.93
+0.26 (3.90%)
At close: May 31, 2024, 4:00 PM
7.02
+0.09 (1.30%)
After-hours: May 31, 2024, 7:33 PM EDT

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $2.22M in the twelve months ending March 31, 2024, down -42.16% year-over-year. Revenue in the quarter ending March 31, 2024 was $620.00K, a -46.74% decrease year-over-year. In the year 2023, Orchestra BioMed Holdings had annual revenue of $2.76M, a decrease of -21.88%.

Revenue (ttm)
$2.22M
Revenue Growth
-42.16%
P/S Ratio
111.92
Revenue / Employee
$39,571
Employees
56
Market Cap
248.01M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

OBIO News

More News